Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Risk Syndrome”

782 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 782 results

Not applicableLooking for participantsNCT06096688
What this trial is testing

Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction

Who this might be right for
Colorectal CancerEndometrial CancerHereditary Cancer Syndromes
Weill Medical College of Cornell University 1,120
Not applicableStudy completedNCT01138124
What this trial is testing

Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD)

Who this might be right for
Renal Pelvis CancerRestless Legs SyndromeEpilepsy+7 more
GlaxoSmithKline 54,202
Not applicableUnknownNCT06277518
What this trial is testing

System for Postoperative Admission to ICU for Patients With Digestive System Malignancy

Who this might be right for
Intensive Care Unit Syndrome
General Hospital of Ningxia Medical University 2,000
Early research (Phase 1)Ended earlyNCT02452983
What this trial is testing

Sertraline in Treatment of Low-Risk Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndromes
Gustavo Rivero 14
Not applicableLooking for participantsNCT07358910
What this trial is testing

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Who this might be right for
DengueChikungunyaZika Virus Infection+55 more
Institut Pasteur du Cambodge 10,000
Not applicableLooking for participantsNCT06450171
What this trial is testing

Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Population: The INFORM Study

Who this might be right for
Cancer Predisposition SyndromePredisposition, Genetic
Dana-Farber Cancer Institute 1,000
Early research (Phase 1)Study completedNCT01300572
What this trial is testing

Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDS

Who this might be right for
Chronic Myelomonocytic LeukemiaPreviously Treated Myelodysplastic SyndromeRecurrent Adult Acute Lymphoblastic Leukemia+3 more
Fred Hutchinson Cancer Center 16
Early research (Phase 1)Ended earlyNCT02641002
What this trial is testing

CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Celgene 28
Not applicableWithdrawnNCT01445275
What this trial is testing

Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199

Who this might be right for
Fallopian Tube CarcinomaHereditary Breast and Ovarian Cancer SyndromeOvarian Carcinoma+1 more
Gynecologic Oncology Group
Early research (Phase 1)Looking for participantsNCT07573111
What this trial is testing

Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute LeukemiaMyelodysplastic Syndrome
Laguna Biotherapeutics, Inc. 12
Testing effectiveness (Phase 2)Study completedNCT00968071
What this trial is testing

Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-risk Myelodysplastic Syndrome

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
M.D. Anderson Cancer Center 71
Testing effectiveness (Phase 2)Study completedNCT00096122
What this trial is testing

Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid Leukemia

Who this might be right for
Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+20 more
National Cancer Institute (NCI) 95
Not applicableStudy completedNCT02113865
What this trial is testing

Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients

Who this might be right for
Acquired Immunodeficiency Syndrome VirusHepatitis, Viral, Non-A, Non-B, Parenterally-TransmittedHepatocellular Carcinoma
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 45
Very early researchStudy completedNCT02117115
What this trial is testing

Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic+1 more
Washington University School of Medicine 21
Early research (Phase 1)Study completedNCT03263637
What this trial is testing

Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies

Who this might be right for
Relapsed or Refractory Haematological Malignancies IncludingAcute Myeloid LeukemiaAcute Lymphocytic Leukemia+8 more
AstraZeneca 44
Testing effectiveness (Phase 2)Study completedNCT00064311
What this trial is testing

Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
National Institutes of Health Clinical Center (CC)
Not applicableStudy completedNCT06359730
What this trial is testing

Incidence and Risk Factors of Low Anterior Resection Syndrome

Who this might be right for
Colorectal Cancer
Zagazig University 120
Testing effectiveness (Phase 2)Study completedNCT01168219
What this trial is testing

Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAdult Acute Megakaryoblastic LeukemiaAdult Acute Monoblastic Leukemia+17 more
National Cancer Institute (NCI) 68
Early research (Phase 1)Study completedNCT01020539
What this trial is testing

Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk Leukemia

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic SyndromeJuvenile Myelomonocytic Leukemia
Columbia University 18
Testing effectiveness (Phase 2)Study completedNCT00656617
What this trial is testing

Phase II Study of Idarubicin, Cytarabine, and Vorinostat With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)
M.D. Anderson Cancer Center 106
Next Page